Moderna’s Flu Vaccine Produces Mixed Results In Final-Stage Trial

Bloomberg (2/16, Langreth, Peebles) reports Moderna’s “influenza vaccine yielded mixed results in a final-stage trial, raising questions about the drugmaker’s plan to seek US approval for a flu shot based on its messenger RNA technology as soon as this ye...